These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 4795102
1. The differentiation of anxiety and depressive disorders: a psychopharmacological approach. Zung WW. Psychosomatics; 1973; 14(6):362-6. PubMed ID: 4795102 [No Abstract] [Full Text] [Related]
2. Clorazepate (tranxene). Another benzodiazepine. Med Lett Drugs Ther; 1972 Nov 10; 14(23):85-6. PubMed ID: 4630756 [No Abstract] [Full Text] [Related]
3. Clorazepate dipotassium in anxiety: a clinical trial with diazepam and placebo controls. Ricca JJ. J Clin Pharmacol New Drugs; 1972 Jul 10; 12(7):286-90. PubMed ID: 4557537 [No Abstract] [Full Text] [Related]
4. Once-a-day potassium clorazepate in anxiety. Magnus RV. Br J Clin Pract; 1973 Dec 10; 27(12):449-52. PubMed ID: 4590788 [No Abstract] [Full Text] [Related]
5. [Study of the injectable form of dipotassic clorazepate in the psychiatric hospital]. Lambert PA, Bouchardy M. J Med Lyon; 1971 May 05; 52(208):763-71. PubMed ID: 5138670 [No Abstract] [Full Text] [Related]
6. [Our experience with Tranxene in adaptation pathology]. de Boucaud M, Gachie JP, Hubert LM, Valencon J. Bord Med; 1972 Mar 05; 5(5):563-74. PubMed ID: 5071679 [No Abstract] [Full Text] [Related]
7. Clinical evaluation of chlorazepate, a new ataractic. Holmgren S. Nord Psykiatr Tidsskr; 1973 Mar 05; 27(1):40-4. PubMed ID: 4569219 [No Abstract] [Full Text] [Related]
8. Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls. Wiersum J. Curr Ther Res Clin Exp; 1972 Aug 05; 14(8):442-8. PubMed ID: 4629306 [No Abstract] [Full Text] [Related]
9. SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials). Itil T, Gannon P, Cora R, Polvan N, Akpinar S, Elveris F, Eskazan E. Behav Neuropsychiatry; 1972 Aug 05; 4(4-5):15-24. PubMed ID: 4566673 [No Abstract] [Full Text] [Related]
10. [Experiences with Wy 4036, a new tranquilizing agent from the benzodiazepine group]. Appel P, Berger I, Harrer G. Arzneimittelforschung; 1971 Jul 05; 21(7):1083-6. PubMed ID: 4935400 [No Abstract] [Full Text] [Related]
11. [Clinical trials of a new anxiolytic, medazepam (Nobrium)]. Boutillier H. Ann Med Psychol (Paris); 1970 Apr 05; 1(4):617-30. PubMed ID: 5450932 [No Abstract] [Full Text] [Related]
12. Clorazepate dipotassium, diazepam and placebo in chronic anxiety. Feurst SI. Curr Ther Res Clin Exp; 1973 Jul 05; 15(7):449-59. PubMed ID: 4198306 [No Abstract] [Full Text] [Related]
13. A comparative trial of medazepam (nobrium) in anxiety-depressive states. Daneman EA. Psychosomatics; 1969 Nov 05; 10(6):366-9. PubMed ID: 4907860 [No Abstract] [Full Text] [Related]
14. [Extension of therapeutic possibilities by a new tranquilizer]. Leube H. Arzneimittelforschung; 1968 Dec 05; 18(12):1566-8. PubMed ID: 5756250 [No Abstract] [Full Text] [Related]
15. [Trial of dipotassium chlorazepate in child psychiatry]. Launay C, Houzel D. Rev Neuropsychiatr Infant; 1972 May 05; 20(5):491-5. PubMed ID: 5081843 [No Abstract] [Full Text] [Related]
17. Clinical trial of dipotassium chlorazepate, a new benzodiazepine derivative. Juhlin L, Opitz B. Nord Psykiatr Tidsskr; 1973 May 05; 27(1):35-9. PubMed ID: 4569218 [No Abstract] [Full Text] [Related]